Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company") a commercial-stage, cancer prevention medical diagnostics company, and majority-owned subsidiary of PAVmed Inc. (Nasdaq: PAVM, PAVMZ) ( "PAVmed"), today announced that it was notified by the World Trade Center Health Program ("WTCHP") that, due to a clerical error, the EsoGuard® Esophageal DNA test was incorrectly listed as a covered benefit. WTCHP advised Lucid on the further steps required, including engaging directly with its Cl
Lucid and Rivian Stock Take a Beating From Wall Street 247wallst.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from 247wallst.com Daily Mail and Mail on Sunday newspapers.